Group 1 - The 2025 Zhongguancun Forum focused on "New Quality Productivity and Global Technological Cooperation," featuring over a hundred high-level activities and attracting more than a thousand global experts and scholars [1] - Aiko Medical showcased its full range of products in the neuro-intervention field, receiving significant attention and recognition from experts and scholars [1] - The Zhongguancun National Independent Innovation Demonstration Zone exhibition highlighted the role of technological innovation in cultivating new quality productivity and providing new ideas for global innovation development [1] Group 2 - Aiko Medical has been invited to the Zhongguancun Forum for two consecutive years to exchange cutting-edge technologies and showcase scientific and technological achievements [2] - The Lattice flow-directed mesh stent, developed by Aiko Medical, is widely used for treating small to medium-sized vertebral artery aneurysms and has the largest approved indication range among similar products [2] - The Lattice stent has a 12-month aneurysm occlusion rate of 91.4% and a stent-related stenosis rate of only 0.8%, significantly outperforming similar products [2] Group 3 - Aiko Medical introduced the Lattice NEXT "no extended head guidewire" flow-directed mesh stent at the forum, expanding its application to treat unruptured saccular or fusiform wide-neck aneurysms in adult patients [3] - The Lattice NEXT design aims to further reduce surgical risks and enhance safety in neuro-intervention procedures [3] Group 4 - Aiko Medical has eight products approved by the NMPA and has filed 132 patent applications, with 73 granted [4] - The Lattice flow-directed mesh stent has been recognized as an "innovative medical device" by the National Medical Products Administration and received expedited approval through a "green channel" [4] - Aiko Medical aims to provide comprehensive innovative solutions for global cerebrovascular disease patients and doctors, fulfilling unmet clinical needs in the field [4]
艾柯医疗携前沿技术参展2025中关村论坛 以创新突破推动神经介入领域发展